Feed BRTX
BR

BioRestorative Therapies, Inc. BRTX · NASDAQ

$1.62 +8.00% (+$0.12)

Market cap
$2.07M
Enterprise value
-$1.01M
P/E
-
Forward P/E
-
PEG
-
P/S
5.8x
P/FCF
-
EV/EBITDA
-
ROIC
-464.9%
Bruto marža
92.1%
Neto marža
-3,089.6%
Dividend yield
-
Payout ratio
-
Neto dolg/EBITDA
-
Beta
0.74
Free float
87.5%

O podjetju

BioRestorative Therapies, Inc. (BRTX) is a biotechnology company focusing on the development and commercialization of therapeutic therapies in the field of regenerative medicine. The company specializes in developing therapeutic products that utilize patients' own cells and tissues to support the healing and regeneration of damaged tissues. BioRestorative Therapies targets the treatment of various health conditions, including orthopedic disorders, degenerative diseases, and more. With the growing interest in regenerative medicine and the need for new treatment approaches, BioRestorative Therapies, Inc. has the potential for sustained growth. BioRestorative Therapies, Inc. (BRTX) shares might be an interesting choice for investors seeking involvement in the biotechnology and regenerative medicine industry.

Sector

Healthcare

Industry

Biotechnology

CEO

Katharyn Field

Employees

14

Headquarters

Melville

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe.